History

Our principals’ experience investing in healthcare spans over 30 years and covers numerous economic cycles and reimbursement paradigms.

Having co-founded Golder, Thoma, Cressey, Rauner (“GTCR”) and Thoma Cressey Equity Partners before founding Cressey & Company, Bryan Cressey helped pioneer the Firm’s “Target, Partner and Build” strategy in the late 1970s and has been investing in successful, growing healthcare businesses ever since.  This strategy, which entails investing in leading platform businesses and accelerating growth both organically and through acquisitions thereafter was and continues to be ideally suited for pursuing investments in the healthcare industry.  The Firm proudly continues to refine and execute this investment strategy.

Cressey & Company’s team had successfully invested in healthcare over three funds at predecessor firm Thoma Cressey Equity Partners (and subsequently Thoma Cressey Bravo) and continues to provide board representation and other management services to the healthcare investments of these predecessor funds through a contractual arrangement with the general partner of those funds.  Cressey & Company was established in June of 2008 and in 2010 held the final closing on Cressey & Company Fund IV, LP, which is focused exclusively on healthcare investments.  Recognizing the growing importance of Nashville in the healthcare community, the Firm opened a Nashville office in 2008.  In addition, Cressey & Company formed a Distinguished Executives Council composed of accomplished healthcare executives who assist the Firm and its portfolio companies on a wide variety of strategic and operational issues.  Cressey & Company is currently investing out of Cressey & Company Fund V, LP, which closed in 2014.

Blockquote

Focus

While many firms with similar pedigrees have grown to focus on larger transactions, the Cressey & Company team is proud to continue its focus on the middle market.  Cressey & Company believes that its business-building experience and resources can uniquely help high-potential younger companies grow into the healthcare leaders of the future.